Making US workers pass genetic test data to employers is wrong
By Martina Cornel,
New Scientist
| 03. 17. 2017
A proposed law effectively allowing US employers to require workers to take DNA tests and hand over the results is misguided
Letting companies require workers to have genetic tests and disclose the results sounds practically dystopian. But that’s the effect of a new congressional bill in the US.
Employees can refuse to comply, but risk being penalised by having to fork out thousands of dollars in extra health insurance payments – the threat of which might be enough to coerce them into going along with it.
This inflammatory proposal has been backed by Republican members of the House of Representatives Committee on Education and the Workforce.
With US employers funding a large chunk of employees’ health insurance, they may, understandably, want to rule out staff having certain health risks, which would in turn keep premiums down. Sure, genetic tests can quantify some of those risks. But the bill blows a huge hole in the principle that genetic testing should be voluntary and directly undermines the US Genetic Information and Non-Discrimination Act (GINA).
What’s more, many of the risk-reducing options...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
